Can Demant (CPSE:DEMANT) Be Revalued As Earnings Improve And Oticon Reveal Launches?
Why Demant’s latest earnings and product launch matter for investors
Demant (CPSE:DEMANT) has just paired half year 2026 earnings, with higher sales and net income, and launched Oticon Reveal, a new AI powered rechargeable hearing aid, putting both financial and product performance in focus.
See our latest analysis for Demant.
At a share price of DKK286.0, Demant has seen a 15.70% 90 day share price return and a 34.02% year to date share price return, while the 5 year total shareholder return is down 19.75%, which suggests recent momentum has picked up after a weaker longer term trend.
If Demant’s AI hearing aid launch has caught your attention, it can also be useful to see what else is happening in related areas of the market, starting with 130 healthcare AI stocks
The share price recovery and fresh AI product story have put Demant back on many watchlists. Does the current valuation still leave enough upside potential to justify the risks buyers would be taking from here?
Most Popular Narrative: 3.3% Overvalued
On the most followed narrative, Demant’s fair value of DKK276.90 sits slightly below the last close at DKK286, which puts the focus firmly on how realistic the embedded growth and margin assumptions really are.
Operational discipline with tightened cost control during periods of weak market growth, alongside plans for efficiency gains and scale benefits from integration, positions Demant to expand margins as volumes recover, enabling a more leveraged return to profit growth once secular demand trends reassert themselves.
The fair value story hinges on a specific playbook. It leans on steadier revenue growth, fatter margins and a future earnings multiple that has to compress from today’s level. Curious which assumptions really move the DKK276.90 figure and how sensitive that value is to even small changes in growth and profitability.
Result: Fair Value of DKK276.90 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Demant’s story can still be knocked off course if weaker market growth persists, and if competition or lower priced regions continue to pressure margins.
Find out about the key risks to this Demant narrative.
Another view on Demant’s valuation
While the fair value narrative tags Demant as about 3.3% overvalued at DKK276.90, the market’s own P/E signals a different message. The stock trades on 24.9x earnings compared with peer averages of 29.6x and a fair ratio of 30.2x. This implies investors are still pricing in some valuation risk if sentiment turns.
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
If this mix of optimism and caution around Demant feels familiar, now is the moment to check the evidence yourself and decide quickly. To see how the upside potential compares with the concerns investors are flagging, review the 3 key rewards and 1 important warning sign.
Looking for more Demant style investment ideas?
If Demant has sharpened your focus, now is the time to widen your watchlist with other stocks that match clear financial qualities and risk profiles.
- Target strong upside potential by checking companies that look mispriced on quality and value using the 271 high quality undervalued stocks.
- Strengthen income in your portfolio by reviewing steady payers and higher yields through the 427 dividend fortresses.
- Reduce unnecessary shocks in your holdings by focusing on resilient companies screened via the 290 resilient stocks with low risk scores.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com